Comparably, at our office, most patients typically lose an average of 8 pounds in the first 2 months
The result of this set of analyses, suggesting that semaglutide is likely to be a cost-effective treatment in Denmark, are supported by publications supporting the cost-effectiveness of semaglutide based on some of the same clinical trials (PIONEER 2 and PIONEER 3) in the context of UK [56] and Swedish [57] healthcare systems
Serious but Rare Side Effects While less common, GLP-1 medications can lead to serious side effects
Another common error involves confusion between units
Obesity experts have called on the NHS to accelerate the use of weight-loss jabs to tackle the obesity crisis, which is linked to numerous long-term conditions including cancer, heart disease, dementia and diabetes, and also puts a huge strain on the health service